The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis
To Elucidate the Epidemiological, Clinical, and Intrinsic Characteristics of Chronic Rhinitis
1 other identifier
observational
150,000
1 country
1
Brief Summary
Chronic rhinitis affects 10-40% of China's population, or over 300 million people, and can lead to respiratory and psychological issues. Despite treatment progress, 30% of patients have poor outcomes, likely due to the disease's complexity and a lack of new treatment targets. The incidence is rising, but there's a lack of nationwide studies on its variations. This study addresses this through a multicentric survey to create a national database on chronic rhinitis, including epidemiological, clinical, and biological data. The goal is to understand chronic rhinitis's causes and risks, improve treatments, and develop preventive strategies. The study will survey 30,000 patients across China, using questionnaires and nasal exams, and preserve biological samples in a biobank for detailed analysis. This will lay the groundwork for understanding the disease's mechanisms, developing new diagnostics, and tailoring prevention and treatment approaches for different forms of chronic rhinitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2024
CompletedFirst Posted
Study publicly available on registry
April 17, 2024
CompletedStudy Start
First participant enrolled
April 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
June 10, 2024
June 1, 2024
3 years
April 12, 2024
June 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The prevalence chronic rhinitis within the Chinese population
The overall prevalence of chronic rhinitis across the Chinese population will be discribed. This will provide a demographic breakdown of how common chronic rhinitis is among various segments of the population.
2024.04-2025.04
Secondary Outcomes (3)
The distribution patterns of chronic rhinitis within the Chinese population
2024.04-2025.04
The risk factors of chronic rhinitis
2024.04-2025.04
The clinical features and endotype of chronic rhinitis
2024.04-2026.04
Study Arms (2)
18000 cases
The first part of the study will use a multi-stage cluster sampling survey, aiming to complete a questionnaire survey of 18,000 cases to assess the incidence and characteristics of chronic rhinitis. Each center will need to complete 3,000 face-to-face questionnaires to ensure reliable survey results.
132000 cases
The second part will involve distributing 132,000 electronic questionnaires to community health service centers through convenient sampling. This method will allow us to obtain a large volume of questionnaire data more conveniently, thereby enhancing our investigation and analysis of chronic rhinitis. Each of the six centers will need to complete 22,000 online questionnaires.
Interventions
Eligibility Criteria
To estimate the incidence of chronic rhinitis in China, we calculate a sample size of roughly 9,471 patients using the formula n = (Z\^2 \* p \* (1-p))/E\^2, with Z = 1.96 for a 95% confidence level, p = 0.2 for a 20% prevalence, and E = 0.015 for a 1.5% margin of error. Our study includes recalling 3,000 patients for nasal exams, implying a need to survey 18 million subjects for a 20% incidence rate and 80% response rate. We'll use a multi-stage cluster sampling survey for 18,000 face-to-face questionnaires and distribute 132,000 electronic questionnaires to reach 30,000 chronic rhinitis patients, assuming a 20% prevalence.
You may qualify if:
- Chinese aged between 18 and 70 years old who have resided at the survey site for more than 6 months within the 12 months preceding the survey.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zheng Liu ENTlead
- Peking Union Medical Collegecollaborator
- Hainan People's Hospitalcollaborator
- Shandong Second Provincial General Hospitalcollaborator
- First Affiliated Hospital of Chongqing Medical Universitycollaborator
- First Affiliated Hospital of Xinjiang Medical Universitycollaborator
Study Sites (1)
Tongji Hosptial affiliated to Tongji Medical college of Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
Related Publications (1)
Makar AB, McMartin KE, Palese M, Tephly TR. Formate assay in body fluids: application in methanol poisoning. Biochem Med. 1975 Jun;13(2):117-26. doi: 10.1016/0006-2944(75)90147-7. No abstract available.
PMID: 1BACKGROUND
Biospecimen
serum, blood cells, urine, nasal secretion
Study Officials
- PRINCIPAL INVESTIGATOR
Zheng Liu
Tongji Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 12, 2024
First Posted
April 17, 2024
Study Start
April 27, 2024
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
June 10, 2024
Record last verified: 2024-06